Sonoma Pharmaceuticals (SNOA) Non-Current Deferred Tax Liability (2016)

Sonoma Pharmaceuticals (SNOA) posted quarterly Non-Current Deferred Tax Liability of $312000.0 for Q4 2016.

Sonoma Pharmaceuticals (SNOA) Non-Current Deferred Tax Liability (2016) Analysis & Trends

Sonoma Pharmaceuticals' Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $312000.0 for Q4 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-
10	Sonoma Pharmaceuticals	5.17 Mn	-165,129.89	2.58 Mn

Download Data

Date	Value
Dec 31, 2016	312,000.00
Dec 31, 2016	312,000.00